“Leading Nanotechnologies” finances an antiepileptic drug development

“Leading Nanotechnologies” finances an antiepileptic drug development“Leading Nanotechnologies”, a venture fund for low-budget projects, financed the development of a new antiepileptic drug. As of today, it’s the first time a fund created with the participation of RUSNANO financed a medical project.

The size of investment per project is not disclosed.





https://www.venture-news.ru/ipo-news/64680-mozhno-li-vyigrat-v-kazino-vsya-pravda-kotoraya-shokiruet-kazhdogo.html